Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | TYR | P14679 | 1/20 | 0.35 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1138588 | 0.89 | RXRA (0.33) | — | |
| SCHEMBL1138710 | 0.85 | RARA (0.31) | — | |
| SCHEMBL30241097 | 0.77 | SMN1; SMN2 (0.45) | SMN1; SMN2ALDH1A1CA2POLBTYR | |
| SCHEMBL2352164 | 0.76 | — | — | |
| SCHEMBL28615973 | 0.76 | SMN1; SMN2 (0.39) | SMN1; SMN2ALDH1A1CA2POLBTYR | |
| SCHEMBL1664850 | 0.75 | SMN1; SMN2 (0.50) | SMN1; SMN2ALDH1A1CA2POLBTYR | |
| SCHEMBL4016569 | 0.75 | TRPV1 (0.32) | CYP2C19 | |
| SCHEMBL1159937 | 0.75 | SMN1; SMN2 (0.48) | SMN1; SMN2ALDH1A1CA2POLBTYR | |
| SCHEMBL30880077 | 0.74 | SMN1; SMN2 (0.39) | SMN1; SMN2ALDH1A1CA2POLBTYR | |
| SCHEMBL4373000 | 0.71 | SMN1; SMN2 (0.50) | SMN1; SMN2ALDH1A1CA2POLBTYR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2006136451-A1 | STABILISED POLYPROPYLENE COMPOSITION | BOREALIS TECHNOLOGY OY (FI) | 2006-12-28 | — | — | WO | claimed |
| EP-1736506-A1 | Stabilised polypropylene composition | Borealis Technology Oy (FI) | 2006-12-27 | — | — | EP | claimed |
| EP-1549704-A1 | STABILIZED POLYMER COMPOSITION | Borealis Technology Oy (FI) | 2005-07-06 | — | — | EP | claimed |
| WO-2004033545-A1 | STABILIZED POLYMER COMPOSITION | BOREALIS TECHNOLOGY OY (FI) | 2004-04-22 | — | — | WO | claimed |
| WO-2024039099-A1 | POLYCARBONATE RESIN COMPOSITION, PREPARATION METHOD THEREFOR, AND MOLDED ARTICLE COMPRISING SAME | (주) 엘지화학 | 2024-02-22 | — | — | WO | disclosed |
| US-8962116-B2 | Pipes made from a polyethylene copolymer with slow crack growth | Borealis A.G. (AT) | 2015-02-24 | — | — | US | disclosed |
| EP-2725057-A1 | Use of an acid scavenger to increase the resistance of a polyolefin composition against disinfectant containing water | Borealis AG (AT) | 2014-04-30 | — | — | EP | disclosed |
| EP-2350153-B1 | METHOD FOR IMPROVING FLOWABILITY OF HETEROPHASIC POLYPROPYLENE POWDER | BOREALIS AG (AT) | 2013-07-31 | — | — | EP | disclosed |
| US-20130122228-A1 | PIPES MADE FROM A POLYETHYLENE COPOLYMER WITH SLOW CRACK GROWTH | BOREALIS AG (AT) | 2013-05-16 | — | — | US | disclosed |
| WO-2012007082-A1 | PIPES MADE FROM A POLYETHYLENE COPOLYMER WITH SLOW CRACK GROWTH | BOREALIS AG (AT) | 2012-01-19 | — | — | WO | disclosed |
| EP-2407506-A1 | Pipes made from a polyethylene copolymer with slow crack growth | Borealis AG (AT) | 2012-01-18 | — | — | EP | disclosed |
| EP-1655303-B1 | Process for the Controlled Increase in Molecular Weight of Polyethylene or Polyethylene Blends | BASF SE (DE) | 2011-02-23 | — | — | EP | disclosed |
| EP-1282630-B1 | Process for Reducing the Molecular Weight of Polypropylene Using Hydroxylamine Esters | CIBA SC HOLDING AG (CH) | 2006-05-10 | — | — | EP | disclosed |
| EP-1655303-A2 | Hydroxylamine esters as polimerization initiators | Ciba SC Holding AG (CH) | 2006-05-10 | — | — | EP | disclosed |
| US-7030196-B2 | Process for reducing the molecular weight of polypropylene | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2006-04-18 | — | — | US | disclosed |
| EP-1549704-A1 | STABILIZED POLYMER COMPOSITION | Borealis Technology Oy (FI) | 2005-07-06 | — | — | EP | disclosed |
| WO-2004033545-A1 | STABILIZED POLYMER COMPOSITION | BOREALIS TECHNOLOGY OY (FI) | 2004-04-22 | — | — | WO | disclosed |
| US-20030216494-A1 | Hydroxylamine esters as polymerization initiators | CIBA SPECIALTY CHEMICALS CORP. | 2003-11-20 | — | — | US | disclosed |
| EP-1282630-A1 | HYDROXYLAMINE ESTERS AS POLYMERIZATION INITIATORS | Ciba SC Holding AG (CH) | 2003-02-12 | — | — | EP | disclosed |
| WO-2001090113-A1 | HYDROXYLAMINE ESTERS AS POLYMERIZATION INITIATORS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2001-11-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030216494-A1 | Hydroxylamine esters as polymerization initiators | PNMT, HPGDS, HAAO | SMN1; SMN2 4814/4885ALDH1A1 941/4885CA2 4765/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.